Patients with irritable bowel disease (IBD) who experience symptoms of anxiety or depression are at an increased risk of poorer disease outcomes including resistance to steroid therapy.1
According to new research from a team of China-based investigators, anxiety and/or depression symptoms were significantly associated with worsened outcomes in IBD management. The findings call for expanded research into the correlation between psychiatric wellness and systemic improvement in IBD care.